Videos - No Videos Found (0)

There are no associated videos to be displayed here.

Henry Ford Transplant App
The Henry Ford Transplant Institute is the most comprehensive multi-organ transplant program in Michigan, and employs aggressive strategies to increase transplant off the wait list while maintaining superior patient outcomes.

We perform transplantation of the:

  • Liver
  • Intestine and Multivisceral organs
  • Kidney
  • Pancreas
  • Heart
  • Lung
  • Bone Marrow Stem Cell

Additionally our abdominal surgeons are the most experienced in the region for treating portal hypertension with various shunting procedures, as well as treating patients with benign and malignant diseases of the liver, pancreas and biliary tract.

More Transplant Videos


Liver Perfusion and Preservation

Doctors at the Henry Ford Transplant Institute, Michigan’s most comprehensive transplant program, have found a new technology that can sustain a donated liver outside of the body for many hours longer than traditionally thought possible.


Robot-Assisted Kidney Transplant

Collaborating with robotic surgery pioneers from the Henry Ford Vattikuti Urology Institute, surgeons at the Henry Ford Transplant Institute have created a new robotic-assisted procedure that offers recipients a faster and safer operation.


The Prevalence and Risk Factors of Skin Cancer in Organ Transplant Recipients

Holly Kerr, MD and Ellen "Nikki" Pritchett, MD discuss the prevelance and risk factors of skin cancer in organ transplant recipients (OTR).


Viral Load Monitoring of CMV/BKV in Transplantation: An Update

Dr. Mayur Ramesh discusses what is the best test for diagnosis/monitoring of CMV/BKV infection in transplant recipients; the clinical indications for VL monitoring of CMV/BKV in a transplant recipient and the utility of international standardization for VL monitoring of CMV/BKV.


Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy

Dr. Edward Peres, associate professor, Department of Internal Medicine, Division of Hematology and Oncology at Henry Ford Hospital, discusses the pathophysiology of graft versus host disease; regulators of GVHD; graft versus leukemia and potential targets and treatment of GVHD.


A Tale of Two Viruses: Recurrent Disease After Transplant

Dr. Dilip Moonka, medical director of the Liver Transplant Program at Henry Ford Hospital, discusses liver transplants for patients with hepatitis b and hepatitis c and how the treatment has evolved.


Communicating Bad News in the Context of Transplantation

Dr. Anita Patel, medical director of Kidney and Pacreas Transplantation and Dr. Anne Eshelman, senior staff health psychologist at the Transplant Institute, discuss why the communication of "bad news" is important and explain the expanded six-step protocol for delivering such news.


Transplant Team Leadership

Dr. Marwan Abouljoud, director, Transplant Institute and Hepatobiliary Surgery, provides perspective on leadership.


Hepatocellular Carcinoma: Optimal Treatment and Transplantation

Dr. Gabriel T. Schnickel, assistant clinical professor in the department of surgery, discusses hepatocellular carcinoma; surgical resection; transplantation and alternative/adjunctive treatments.


Fulminant Hepatic Failure Due to Acetaminophen Overdose

Dr. Anne Eshelman, discusses acetaminophen overdose and presents two cases.


Portopulmonary Hypertension: A Curable Disease?

Dr. Sana Quddus, assistant professor of pulmonary and critical care medicine, examines the natural history of portopulmonary hypertension, discusses when a liver transplant can be done safely and explores what happens after transplantation.


Ethical Issues in Live Donor Kidney Transplantation: Illustrative Case-Vignettes

Dr. K.K. Venkat, transplant nephrologist, presents case studies involving ethical decision making.


Continuous Quality Improvement: Lessons Learned from the Kidney Transplant Program

Dr. Dean Kim, surgical director of Kidney and Pancreas Transplantation at Henry Ford Hospital, discusses kidney transplant and quality improvement and quality assurance.